GB9102727D0 - Pharmaceutical agent - Google Patents

Pharmaceutical agent

Info

Publication number
GB9102727D0
GB9102727D0 GB919102727A GB9102727A GB9102727D0 GB 9102727 D0 GB9102727 D0 GB 9102727D0 GB 919102727 A GB919102727 A GB 919102727A GB 9102727 A GB9102727 A GB 9102727A GB 9102727 D0 GB9102727 D0 GB 9102727D0
Authority
GB
United Kingdom
Prior art keywords
pharmaceutical agent
pharmaceutical
agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB919102727A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Imperial Chemical Industries Ltd
Original Assignee
Imperial Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Imperial Chemical Industries Ltd filed Critical Imperial Chemical Industries Ltd
Priority to GB919102727A priority Critical patent/GB9102727D0/en
Publication of GB9102727D0 publication Critical patent/GB9102727D0/en
Priority to IE024392A priority patent/IE920243A1/en
Priority to IL100793A priority patent/IL100793A0/xx
Priority to ZA92729A priority patent/ZA92729B/xx
Priority to APAP/P/1992/000355A priority patent/AP9200355A0/en
Priority to GB9202377A priority patent/GB2252557A/en
Priority to HU9200354A priority patent/HUT60489A/hu
Priority to AU11893/92A priority patent/AU1189392A/en
Priority to PCT/GB1992/000214 priority patent/WO1992013853A1/fr
Priority to PT100097A priority patent/PT100097A/pt
Priority to CA002060825A priority patent/CA2060825A1/fr
Priority to MX9200532A priority patent/MX9200532A/es
Priority to CN92101425A priority patent/CN1064809A/zh
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
GB919102727A 1991-02-08 1991-02-08 Pharmaceutical agent Pending GB9102727D0 (en)

Priority Applications (13)

Application Number Priority Date Filing Date Title
GB919102727A GB9102727D0 (en) 1991-02-08 1991-02-08 Pharmaceutical agent
IE024392A IE920243A1 (en) 1991-02-08 1992-01-27 Therapeutic agent
IL100793A IL100793A0 (en) 1991-02-08 1992-01-28 Therapeutic agents
ZA92729A ZA92729B (en) 1991-02-08 1992-01-31 Pharmaceutical agent
APAP/P/1992/000355A AP9200355A0 (en) 1991-02-08 1992-02-03 "Therapeutic agent"
PCT/GB1992/000214 WO1992013853A1 (fr) 1991-02-08 1992-02-05 Agent therapeutique
HU9200354A HUT60489A (en) 1991-02-08 1992-02-05 Process for producing 2-ethyl-4-/(2'-/1h-tetrazol-5-yl/-biphenyl-4-yl)-methoxy/-quinoline hydrochloride and pharmaceutical compositions comprising same
GB9202377A GB2252557A (en) 1991-02-08 1992-02-05 Quinoline derivative
AU11893/92A AU1189392A (en) 1991-02-08 1992-02-05 Pharmaceutical agent
PT100097A PT100097A (pt) 1991-02-08 1992-02-06 Novos agentes terapeuticos constituidos por derivados de quinolina e processo para a sua preparacao
CA002060825A CA2060825A1 (fr) 1991-02-08 1992-02-07 Agent therapeutique
MX9200532A MX9200532A (es) 1991-02-08 1992-02-07 Agente farmaceuticos.
CN92101425A CN1064809A (zh) 1991-02-08 1992-02-08 药剂

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB919102727A GB9102727D0 (en) 1991-02-08 1991-02-08 Pharmaceutical agent

Publications (1)

Publication Number Publication Date
GB9102727D0 true GB9102727D0 (en) 1991-03-27

Family

ID=10689748

Family Applications (2)

Application Number Title Priority Date Filing Date
GB919102727A Pending GB9102727D0 (en) 1991-02-08 1991-02-08 Pharmaceutical agent
GB9202377A Withdrawn GB2252557A (en) 1991-02-08 1992-02-05 Quinoline derivative

Family Applications After (1)

Application Number Title Priority Date Filing Date
GB9202377A Withdrawn GB2252557A (en) 1991-02-08 1992-02-05 Quinoline derivative

Country Status (12)

Country Link
CN (1) CN1064809A (fr)
AP (1) AP9200355A0 (fr)
AU (1) AU1189392A (fr)
CA (1) CA2060825A1 (fr)
GB (2) GB9102727D0 (fr)
HU (1) HUT60489A (fr)
IE (1) IE920243A1 (fr)
IL (1) IL100793A0 (fr)
MX (1) MX9200532A (fr)
PT (1) PT100097A (fr)
WO (1) WO1992013853A1 (fr)
ZA (1) ZA92729B (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW297025B (fr) * 1992-02-14 1997-02-01 Squibb & Sons Inc
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
JP5546451B2 (ja) 2007-06-04 2014-07-09 シナジー ファーマシューティカルズ インコーポレイテッド 胃腸の障害、炎症、癌および他の障害の処置に有用なグアニル酸シクラーゼのアゴニスト
AU2009256157B2 (en) 2008-06-04 2014-12-18 Bausch Health Ireland Limited Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
WO2010009319A2 (fr) 2008-07-16 2010-01-21 Synergy Pharmaceuticals Inc. Agonistes de guanylate cyclase utiles pour le traitement de troubles gastro-intestinaux, inflammatoires, cancéreux et autres
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
CA2905435A1 (fr) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Compositions utiles pour le traitement de troubles gastro-intestinaux
WO2014151206A1 (fr) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Agonistes de la guanylate cyclase et leurs utilisations
US10011637B2 (en) 2013-06-05 2018-07-03 Synergy Pharmaceuticals, Inc. Ultra-pure agonists of guanylate cyclase C, method of making and using same
WO2015036792A1 (fr) 2013-09-16 2015-03-19 Astrazeneca Ab Nanoparticules polymères thérapeutiques et leurs procédés de fabrication et d'utilisation

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4920132A (en) * 1987-11-03 1990-04-24 Rorer Pharmaceutical Corp. Quinoline derivatives and use thereof as antagonists of leukotriene D4
EP0412848B1 (fr) * 1989-08-11 1995-01-18 Zeneca Limited Dérivés de quinoléine, procédés pour leur préparation et leur utilisation comme médicaments

Also Published As

Publication number Publication date
PT100097A (pt) 1993-04-30
HUT60489A (en) 1992-09-28
MX9200532A (es) 1992-08-01
GB9202377D0 (en) 1992-03-18
AU1189392A (en) 1992-09-07
ZA92729B (en) 1992-11-25
IE920243A1 (en) 1992-08-12
AP9200355A0 (en) 1993-08-03
WO1992013853A1 (fr) 1992-08-20
GB2252557A (en) 1992-08-12
CA2060825A1 (fr) 1992-08-09
HU9200354D0 (en) 1992-04-28
IL100793A0 (en) 1992-09-06
CN1064809A (zh) 1992-09-30

Similar Documents

Publication Publication Date Title
PL304317A1 (en) Pharmaceutical agent
IL100091A0 (en) Pharmaceutical agents
IL102777A0 (en) Pharmaceutical combination formulation
PL304508A1 (en) Pharmaceutical agent
AP9200356A0 (en) Pharmaceutical composition
GB9108080D0 (en) Pharmaceutical composition
GB9114950D0 (en) Pharmaceutical formulation
HU9300804D0 (en) Pharmaceutical preparatives
GB9202377D0 (en) Pharmaceutical agent
GB9216061D0 (en) Pharmaceutical combination formulation
GB9000241D0 (en) Pharmaceutical use
GB2252497B (en) Pharmaceutical composition
PL297548A1 (en) Pharmaceutical agent
GB9104124D0 (en) Pharmaceutical agent
GB9104123D0 (en) Pharmaceutical agent
GB9111477D0 (en) Pharmaceutical composition
GB9115107D0 (en) Pharmaceutical agents
GB9113622D0 (en) Medicinal agents
ZA924842B (en) Asialoglycoprotein-conjugated medicinal agent
GB9113943D0 (en) New pharmaceutical use
GB9113918D0 (en) New pharmaceutical use
GB9104269D0 (en) New pharmaceutical use
GB9113850D0 (en) New pharmaceutical use
GB9104306D0 (en) New pharmaceutical use
GB9123204D0 (en) New pharmaceutical use